I received an email from empower saying the FDA is cracking down on enclomiphene, anyone have additional information?
They have vested interests in Pharmaceutical corporations, if you’ve watched the Appointee/Leadership turnover rate at the FDA you’re going to see a disturbing trend, most leave the FDA to become consultants or CEOs of spin-off (P & M) corporations. It’s quite sickening, it’s right up there with RICO and insider trading.Listened through the FDA meeting questions and answers and it's frustrating that they are voting on therapies that they know so little about